Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
WITHDRAWN
NCT04761978
Efficacy and Tolerance of JAK Inhibitors in ATU for Atopic Dermatitis
Sponsor: University Hospital, Lille
View on ClinicalTrials.gov
Summary
The aim is to assess effectiveness (EASI, SCORAD, IGA, DLQI, pruritus, sleep loss) and safety (clinical and biological adverse events) of JAK inhibitors in adults with moderate-to-severe atopic dermatitis in a real-life French multicenter retrospective cohort
Official title: Effectiveness and Safety of JAK Inhibitors for the Treatment of Moderate-to-severe Atopic Dermatitis in a Real-life French Multicenter Adult Cohort
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
0
Start Date
2021-09-01
Completion Date
2022-09-01
Last Updated
2026-05-22
Healthy Volunteers
Yes
Conditions
Locations (1)
Hop Claude Huriez Chu Lille
Lisle-sur-Tarn, France